S W Smith1, W G Billotte, D Krane
1Department of Biology, University of Dayton, Dayton, OH 45469, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Hydroxyapatite (HA) ceramics offer controlled release of Interleukin-2 (IL-2) for cancer therapy. Varying the HA to IL-2 ratio in ceramic pellets adjusts drug delivery rates, optimizing cancer treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: